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CLINICAL TOXICOLOGY

concealed in an unplanned manner and tend to be poorly
wrapped. This heterogeneity in packaging material, as well as
xenobiotic concealed, pose unique challenges regarding potential
retrieval and degree of toxicity.
Case report: This is a single patient chart review. A 30-year-old
male presented to the Emergency Department after ingesting
a plastic bag containing 15 tablets of MDMA (3,4Methylenedioxymethamphetamine). The patient was under arrest by
police and ingested the package in an attempt to avoid detection.
The patient presented to the Emergency Department with stable
vital signs and only reporting mild anxiety. He received plain films of
his abdomen, which revealed a potential foreign body. A subsequent
CT abdomen and pelvis revealed multiple foreign bodies in the area
of his gastric fundus. The patient was admitted to the hospital for
continuous monitoring and potential retrieval of the package. The
patient had repeat plain films 6 h into his stay, which revealed that
the foreign body had not progressed. Gastroenterology was consulted and the patient underwent successful endoscopic retrieval of
the plastic bag with contents. Repeat plain films showed no retained
foreign bodies and patient was discharged in stable condition.
Discussion: The potential interventions for body stuffers are limited and each has potential pitfalls. Whole bowel irrigation can
result in rupture of contents and is no guarantee that the product ingested will pass. Similar patients can potentially take up
hospital and critical care beds for prolonged periods of time
while awaiting the passage of xenobiotic packages. When endoscopic retrieval is an option, it can greatly decrease the length of
stay of a patient in a safe, effective manner.
Conclusions: Body stuffers pose unique challenges to medical
toxicologists regarding monitoring and potential retrieval of
ingested xenobiotics. Endoscopy and retrieval can be useful and
potentially decrease length of stay in these patients.
KEYWORDS Body stuffer; MDMA; endoscopy
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160. The importance of emphasizing
addiction medicine during medical
toxicology fellowship training: a case
study of a tertiary care hospital
system toxicology consultation service
Nicholas Imperato, Chase Jones, Derek Fikse, Gillian
Beauchamp, Marna Greenberg, Katelyn McLain and
Alexandra Amaducci
Lehigh Valley Health Network/USF Morsani College of Medicine,
Allentown, PA, USA
Background: As we continue to treat patients during the
ongoing opioid overdose epidemic, it is ever more important
that providers have adequate experience in understanding and
treating patients with addiction, substance use disorder and
withdrawal states. Additionally, throughout the COVID-19 pandemic, there have been numerous reports demonstrating that
substance use is exponentially increasing. This increases the likelihood that addiction medicine will occupy a more prominent position in our medical field. Until recently, addiction medicine
education was not an ACGME program requirement for medical
toxicology fellowship programs. We aimed to evaluate the percentage of bedside medical toxicology consultations addressing
addiction-related issues, over time, at a tertiary care hospital
system.
Methods: We reviewed bedside toxicology consults performed
by a tertiary care hospital system’s Division of Medical Toxicology
consultation service between January 2017 and December 2021
for addiction, substance use, and withdrawal-related cases.
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Consultation data is entered by bedside toxicologists and maintained in a secure database. Descriptive statistics were analyzed
for various variables and were compared between years, utilizing
SPSS28.
Results: Over the 5-year period, the toxicology service was consulted on a total of 4733 patients, of which, 2549 were addiction-related (53.9%). The majority of consults were male (65.6%),
with 1 transgender (male-to-female) patient treated during this
time. The proportion of addiction medicine consults increased
steadily over the five-year time period. In 2017, there were 345
total consults, with 88 addiction-related (25.5%). In 2018, the service was consulted on 509 patients, of which 168 were addiction
related (33%). In 2019, this trend continued to increase, with
addiction medicine consults accounting for 52.8% of the total
consults (478 of 905 consults). 58.7% of the toxicology services’
consults were addiction related in 2020 (627 of 1069). As of this
past year, of the 1905 total consults, 1188 were for addiction or
substance-use complaints (62.4%). The most common primary
reason for a medical toxicologist consult, was alcohol withdrawal
(803 cases, 31.5%). In 2021, alcohol withdrawal accounted for
44.2% of the total consults, which was a 25.7% increase from
pre-pandemic levels. Opioid withdrawal as the primary reason for
consultation accounted for 9.1% of total consults across the
time-period. In 2017, opioid withdrawal accounted for 2.3% of
consults, but increased to 13.0% of the consultations by 2021.
Opioid agonist therapy (buprenorphine, methadone) was initiated in 12.7% of total consults. In 2017, there were no cases
where opioid agonist therapy was a topic of consultation, but
this increased to 12.0% of consults throughout 2021.
Conclusions: At a tertiary care hospital system, addiction medicine consults by bedside medical toxicologists have continued to
increase disproportionately compared to other consults. As of
this past year, addiction related complaints made up roughly
two-thirds of all medical toxicology consults, increasing almost
40% over 5-years. This single center phenomenon could represent a national trend; however, larger-scale studies would need
to assess this pattern. This data further supports the recent
ACGME medical toxicology program requirement changes,
emphasizing the importance of addiction medicine and its relationship to medical toxicology.
KEYWORDS Addiction medicine; public trends; medical education
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161. Intentional self-harm overdoses
before and during the COVID-19
pandemic in adolescents managed by
a medical toxicology consultation
service
Samantha Gaetani, Natalie Ebeling-Koning, Nicholas
Imperato, Katelyn McLain, Derek Fikse, Gillian
Beauchamp, Marna Greenberg and Alexandra
Amaducc
Lehigh Valley Health Network/USF Morsani College of Medicine,
Allentown, PA, USA
Background: Since March 2020 to the present, the world has
been coping with the COVID-19 pandemic and the associated
social ramifications. It has impacted community mental health,
with several studies demonstrating an increase in anxiety and
depression among adults and adolescents during the pandemic.
The reasons are multifactorial, however, may be related to a
decrease in access to outpatient appointments, social distancing,
financial hardships, loss of loved ones, and closures of schools,
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ABSTRACT

jobs, and recreational activities. We aimed to review adolescent
intentional self-harm overdose cases presenting to our tertiary
care hospital system’s medical toxicology consultation service
prior to and during the pandemic.
Methods: We reviewed bedside medical toxicology consultations
from May 2018–February 2020 (22 months pre-COVID-19) and
March 2020–December 2021 (22 months during COVID-19) for
self-harm cases in adolescents ages 10–19 years old. Descriptive
analysis was performed on these groups for variables including
number of self-harm cases, number of intentional overdoses, age,
sex, and primary agent used.
Results: The total number of intentional ingestions in adolescents 10–19 years old from May of 2018-December of 2021 was
396: there were 174 cases between May 2018-February 2020
with 95 cases (54.5%) being self-harm cases, and 222 cases
between March 2020-December 2021 with 145 (65.3%) cases
being self-harm cases. Of the 95 intentional self-harm overdoses
in the pre-COVID-19 timeframe, analgesics were the most commonly used medication class (n ¼ 29; 30.5%). Analgesic medications included acetaminophen, aspirin, and ibuprofen.
Acetaminophen was the most commonly used medication for
overdose from May of 2018–February 2020 (n ¼ 21; 23.1%).
Antidepressants were the next largest group of medications used
(n ¼ 13; 27.4%). The other overdose xenobiotics pre-COVID-19
were anticonvulsants (n ¼ 5; 5.3%), anticholinergic/antihistamine
(n ¼ 13; 13.7%), antimicrobials (n ¼ 2; 2.1%), antipsychotics (n ¼ 8;
8.4%), cardiovascular medications (n ¼ 4; 4.2%), lithium (n ¼ 1),
iron (n ¼ 1), opioids (n ¼ 1), and sedatives-hypnotics (n ¼ 5; 5.3%).
In the pre-COVID19 time period, cases were 84.2% female
(n ¼ 80), 13.7% male (n ¼ 13), and 2.1% (n ¼ 2) transgender
(male-to-female, female-to-male, and gender non-conforming). In
the 145 self-harm cases during the COVID-19 timeframe, analgesics were most commonly used (n ¼ 47; 32.4%), and acetaminophen was the most common medication used overall (n ¼ 35;
24.1%). Antidepressants were involved in 31% (n ¼ 45). Other
agents were ethanol (n ¼ 1), methanol (n ¼ 1), anticholinergic/
antihistamine (n ¼ 1), anticonvulsants (n ¼ 8; 5.5%), antimicrobials
(n ¼ 1), antipsychotics (n ¼ 6; 4.1%), cardiovascular medications
(n ¼ 8; 5.5%), caustic (n ¼ 1), dextromethorphan (n ¼ 1), lithium
(n ¼ 2; 1.4%), opioids (n ¼ 3; 2.1%), sedative hypnotics (n ¼ 5;
3.4%), and sympathomimetics (n ¼ 2; 1.4%). Out of this group,
78.6% (n ¼ 114) were female, 16.6% (n ¼ 24) were male, and 4.8%
(n ¼ 7) were transgender.
Conclusions: In the COVID-19 time period, there was an increase
in self-harm cases and intentional overdoses. The most common
medications used for intentional overdose during both time periods were analgesics and antidepressants, with the most commonly used agent being acetaminophen. The majority of
intentional self-harm cases were among females. Future research
could focus on larger scale epidemiological data on self-harm
overdoses to determine the impact of the pandemic on mental
health.
KEYWORDS Intentional overdose; adolescent; COVID
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162. Poison center penetrance,
utilization, and call distribution
2016–2020
Hayley Gartner, Adam Overberg and Shannon
Penfound
Indiana University Health/Indiana Poison Center, Indianapolis,
IN, USA
Background: Poison center utilization has been associated with
decreased emergency department visits, hospitalization rates,

and total healthcare expenditure. Assessment of poison center
utilization is necessary to increase public awareness and promote
effective outreach. This study aims to describe utilization trends
and county changes in call volume over time. Penetrance as a
measure of poison center utilization is the annual rate of human
exposure calls per population and varies by many social, economic, and geographic factors. Geospatial mapping and analysis
of penetrance may reveal poison center underutilization and
identify areas for targeted outreach.
Methods: A single-center, retrospective study of closed, human
exposure calls to a poison center was conducted between
January 1, 2016, and December 31, 2020. Patient demographics
included age, gender, medical outcomes, and exposure reason.
Penetrance was assessed by cross-linking poison center data with
county-level population statistics from the US Census Data.
Linked data were stratified by adult, elderly, and pediatric subsets. Percent change of county-level call volume and county-level
penetrance was assessed over 1-year and 5-year periods and
geospatially visualized using Quantum Geographic Information
System (QGIS).
Results: Of the 92 state counties, 14 counties had a decrease in
penetrance of greater than 20% between 2019 and 2020 compared to 6 counties in 2018 and 2019. A total of 8 counties had
an increase in penetrance of greater than 15% from 2018 to
2019 compared to 27 counties in 2019 and 2020. Overall, data
demonstrated a decreased number of calls between 2016 and
2020. Decreases were consistent across all age groups over time
(p < 0.001). Contrarily, increased admissions to psychiatric care
and noncritical care units were found. Medical outcome analysis
revealed an increase in major effects and a decrease in the number of minor effects over time.
Conclusions: Poison center penetrance is variable by geographic
location. Future studies should include an assessment of county
socioeconomic and demographic variables. Understanding the
distribution of poison center calls is essential for improving
resource allocation and increasing poison center access across
the state.
KEYWORDS Utilization; penetrance; center
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163. Minimal recovery of drug from
extracorporeal treatment in a case of
phenytoin toxicity associated with
coma and hypothermia
Joshua Blooma, Ami Desai Gadirajub, Amol Mittalb,
Robert S. Hoffmanc and Mark Suc
a
Division of Medical Toxicology, NYU Grossman School of
Medicine, New York, NY, USA; bDepartment of Internal Medicine,
White Plains Hospital, White Plains, NY, USA; cNYC Poison Center,
New York, NY, USA

Background: The Extracorporeal Treatments in Poisoning
(EXTRIP) workgroup provides a weak conditional recommendation in support of hemodialysis (HD) for select patients with
severe phenytoin poisoning. Despite this recommendation, the
HD clearance of phenytoin is poorly studied. We present a
patient who developed phenytoin toxicity that was treated with
hemodialysis and report on the efficacy of phenytoin removal
during HD.
Case report: An 87-year-old man with epilepsy who was maintained on a stable dose of 300 mg phenytoin extended-release
daily was admitted to the hospital for treatment of Coronavirus
Disease 2019 and congestive heart failure. On hospital day 14,
the patient had a gradual onset of depressed mental status with

